Uncategorized

Will Glaxo do anything to keep Avandia on the market?

Federal regulators have debated for several years whether or not diabetes drug Avandia should remain on the market. The problem is that it seems to raise the risk of heart attacks and Avandia is not the only drug of its kind available.

But Glaxo, which makes Avandia, was frightened that one of its big sellers would get yanked from the shelves, so the company began pressuring scientists, including Dr. John Buse at UNC, to drop the criticism. The drug maker’s behavior was appalling.

Now the FDA is examining the drug again and asked the company to send a letter to physicians summarizing the federal hearing where researchers presented evidence against Avandia. The doctors are part of a drug trial comparing Avandia to another drug. But the trial raises ethical issues because Avandia may be dangerous.

Let’s just say that more than a few people thought the letter sent by Glaxo glossed over some critical information.

This is a crucial issue for many consumers around the country, and many lives are certainly at stake. Glaxo should stop pushing Avandia at all costs, and it’s time we let the science speak.

4 Comments


  1. […] News: Diabetes Meds Associated With Fracture RiskNurse.comTheHeart.Org -The Progressive Pulse (blog) -FiercePharmaall 29 news […]

  2. […] Official, Advisors Call GSK Letter About Avandia Review MisleadingAboutLawsuits.comNurse.com -The Progressive Pulse (blog) -FiercePharmaall 33 news […]

  3. […] drug "as safe as rival"Pharmacy EuropeNurse.com -AboutLawsuits.com -The Progressive Pulse (blog)all 55 news […]

  4. PrettyOldLady

    August 25, 2010 at 1:24 pm

    This makes me boiling ANGRY!! The diabetes drug makers make bilions every month of the people this is SICK. The FDA always approves the drugs and then recalls them after the drug companies get richer. A European filmmaker has been reversing diabetes in 10 countries WITHOUT MEDICATIONS! and the drug companies do not promote the story

    just google SPIRIT HAPPY DIET

Check Also

Context is key for understanding Insurance Commissioner’s Affordable Care Act comments

Many people were surprised to see a story ...

Top Stories from NCPW

  • News
  • Commentary

A key House committee signed off on the chamber’s public school budget report Thursday, despite Demo [...]

Harold Brubaker, the former Republican House Speaker turned powerful lobbyist, tried to ram through [...]

A bill to limit local regulation of small cell towers is moving to a full House vote, despite concer [...]

The U.S. Supreme Court ruled Monday that the North Carolina GOP drew unconstitutionally racially ger [...]

The most shameful thing about the disastrous budget passed by the Senate two weeks ago is not the vi [...]

Court setbacks, public opinion, progressive activism and Trump bode ill for NC conservatives Profess [...]

So, the question as always comes down to one of vision. The elected chieftains who decide how much m [...]

2.8 billion---amount in dollars of needs in communities across the state for rebuilding efforts from [...]

Featured | Special Projects

Trump + North Carolina
In dozens of vitally important areas, policy decisions of the Trump administration are dramatically affecting and altering the lives of North Carolinians. This growing collection of stories summarizes and critiques many of the most important decisions and their impacts.
Read more


HB2 - The continuing controversy
Policy Watch’s comprehensive coverage of North Carolina’s sweeping anti-LGBT law.
Read more